Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Post- and Pre-dilutional Hemodiafiltration on Patients With End-stage Renal Disease

NCT03288285 is registered in ClinicalTrials.gov with Tungs' Taichung Metroharbour Hospital as lead sponsor.

NCT NCT03288285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03288285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Post- and Pre-dilutional Hemodiafiltration on Patients With End-stage Renal Disease
Lead sponsor
Tungs' Taichung Metroharbour Hospital
Phase
Observational
Overall status
Completed
Start date
September 1, 2017
Completion date
April 7, 2019
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodiafiltration